BRIEF published on 08/30/2025 at 02:15, 8 months 24 days ago Résultats financiers de GLG Life Tech Corporation au deuxième trimestre 2025 Résultats Financiers Baisse Des Revenus Gestion Des Coûts GLG Life Tech Marché De La Stévia
PRESS RELEASE published on 08/30/2025 at 02:10, 8 months 24 days ago GLG Life Tech Corporation Reports 2025 Second Quarter Financial Results GLG Life Tech Corporation announces financial results for the three and six months ended June 30, 2025, including revenue decrease of 22% and net income increase. Company emphasizes managing SG&A expenses Financial Results Revenue Decrease GLG Life Tech Corporation Net Income Increase SG&A Expenses
BRIEF published on 05/31/2025 at 01:50, 11 months 23 days ago GLG Life Tech Corporation annonce une baisse de son chiffre d'affaires au premier trimestre 2025 Baisse Des Revenus GLG Life Tech Cotation NEX Résultats Financiers 2025 Marché De La Stévia
BRIEF published on 05/31/2025 at 01:50, 11 months 23 days ago GLG Life Tech Corporation Reports Decline in First Quarter 2025 Revenue Revenue Decline GLG Life Tech NEX Listing 2025 Financial Results Stevia Market
PRESS RELEASE published on 05/31/2025 at 01:45, 11 months 23 days ago GLG Life Tech Corporation Reports 2025 First Quarter Financial Results GLG Life Tech Corporation reports Q1 2025 financial results, with $3.2 million in revenues, a decrease from Q1 2024. Company focuses on managing SG&A expenses and reducing net loss Revenues Financial Results Net Loss GLG Life Tech Corporation SG&A Expenses
BRIEF published on 05/01/2025 at 05:30, 1 year ago Défis financiers et ajustements stratégiques de GLG Life Tech Corporation en 2024 Résultats Financiers Croissance Des Revenus Réduction De La Dette Défis Réglementaires Ajustements Stratégiques
BRIEF published on 05/01/2025 at 05:30, 1 year ago GLG Life Tech Corporation's 2024 Financial Challenges and Strategic Adjustments Financial Results Revenue Growth Debt Reduction Regulatory Challenges Strategic Adjustments
PRESS RELEASE published on 05/01/2025 at 05:25, 1 year ago GLG Life Tech Corporation Reports 2024 Annual & Fourth Quarter Financial Results GLG Life Tech Corporation announces financial results for Q4 2024, reporting revenues of $4.0M (8% decrease) and gross profit of $0.6M. Company also discloses corporate developments and future outlook Revenues Financial Results Gross Profit GLG Life Tech Corporation Corporate Developments
BRIEF published on 11/30/2024 at 02:40, 1 year 5 months ago GLG Life Tech Reports Strong Q3 2024 Financial Performance Revenue Growth Financial Restructuring GLG Life Tech Runde Subsidiary Transfer Q3 2024 Results
BRIEF published on 11/30/2024 at 02:40, 1 year 5 months ago GLG Life Tech annonce de solides résultats financiers au troisième trimestre 2024 Restructuration Financière Croissance Des Revenus Résultats Du 3ème Trimestre 2024 Technologie De La Vie GLG Transfert De La Filiale Runde
Published on 05/23/2026 at 03:00, 2 minutes ago Battery X Metals Reports Up to ~84 km Estimated Driving Range Increase Across Multiple BYD Electric Vehicles Following Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Trials, Demonstrating Performance Improvement Across the World’s Larges
Published on 05/23/2026 at 02:25, 37 minutes ago Battery X Metals Announces up to $2 Million Private Placement Financing and Initiative to Strengthen Balance Sheet
Published on 05/23/2026 at 02:25, 37 minutes ago Bolt Metals Completes 402 line-km MobileMT Survey at Northwind Property, Quebec
Published on 05/23/2026 at 01:00, 2 hours 2 minutes ago LIR Life Sciences Announces Initiation of Phase 1 Macromolecule-Enabled Transdermal Delivery Development with Neuland Laboratories
Published on 05/23/2026 at 00:55, 2 hours 7 minutes ago GLG Life Tech Corporation Reports 2026 First Quarter Financial Results
Published on 05/22/2026 at 22:05, 4 hours 57 minutes ago Abivax présente ses résultats financiers du T1 2026 et les données à trois ans de l’étude 108, un essai d’extension ouvert de phase 2a/2b évaluant l’obéfazimod après réduction de dose dans la RCH
Published on 05/22/2026 at 22:05, 4 hours 57 minutes ago Abivax Presents Q1 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with UC
Published on 05/22/2026 at 19:51, 7 hours 11 minutes ago Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Redemption Prices
Published on 05/22/2026 at 18:33, 8 hours 29 minutes ago Update on Coupon payment due on 23 May 2026 and Preparation of the Green Bond Restructuring
Published on 05/22/2026 at 18:30, 8 hours 32 minutes ago Annual General Meeting of Curatis Holding AG approved all proposals of the Board of Directors
Published on 05/22/2026 at 19:35, 7 hours 27 minutes ago PROJET D'EVOLUTION DE SA GOUVERNANCE ET LA NOMINATION D'UN PRESIDENT DU DIRECTOIRE PAR INTERIM
Published on 05/22/2026 at 18:05, 8 hours 56 minutes ago Déclaration hebdomadaire d'opérations effectuées du 18 au 22 mai 2026
Published on 05/22/2026 at 18:05, 8 hours 56 minutes ago Disclosure of transactions in own shares from May 18 to May 22, 2026
Published on 05/22/2026 at 12:52, 14 hours 9 minutes ago Communiqué du Conseil d’administration – Assemblée Générale du 22 mai 2026
Published on 05/22/2026 at 12:52, 14 hours 9 minutes ago Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026
